findmyKOL

Tomasz Stryjewski, MD

Basic profile

Massachusetts General Hospital

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Tomasz Stryjewski is an Ophthalmology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 58 publications with 563 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
58publications

Distinct works indexed by OpenAlex, matched via ORCID.

563citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    81.3%
    Antineovascularisation agents70.4%
    Faricimab-svoa100%
    Part B, office-administered25 patients
    Vascular Endothelial Growth Factor Inhibitor4.1%
    Ranibizumab100%
    Part B, office-administered11 patients

    + 6 more classes in this area

  • Cancer & immunology

    16%
    Vascular Endothelial Growth Factor Inhibitor16%
    Aflibercept91%Bevacizumab9%
    Part B, office-administered126 patients
  • Musculoskeletal

    2%
    Cyclooxygenase Inhibitor2%
    Ketorolac Tromethamine100%
    Part D76 patients
Where care is delivered (Part B)0.4% facility · 99.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”